Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Bicarbonate for Prevention of Contrast Induced Nephropathy
NCT00392405Phase 2Unknown
- Sponsor
- Norton Community Hospital
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sodium bicarbonate in contrast-induced nephropathy (CIN) (2 arms), sponsored by Norton Community Hospital. Primary endpoint: Development of contrast-induced nephropathy at 48 hours. Status: unknown.
02
Drugs
sodium bicarbonate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00392405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00392405.